Disclosures for "Optimizing Management and Outcomes of Large Vessel Occlusion Ischemic Stroke Utilizing Mobile Stroke Units")
-
Dr. Tariq has nothing to disclose.
-
Stephanie Parker has nothing to disclose.
-
Dr. Jacob has nothing to disclose.
-
Mengxi Wang has nothing to disclose.
-
Noopur Singh has nothing to disclose.
-
The institution of Jose-Miguel Yamal has received research support from NIH/DoD.
-
Mr. Phan has nothing to disclose.
-
Ms. Bratina has nothing to disclose.
-
Dr. Bowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
-
Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. The institution of Dr. Grotta has received research support from Genentech. The institution of Dr. Grotta has received research support from CSL Behring. The institution of Dr. Grotta has received research support from Chiesi. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Czap has received research support from SVIN. The institution of Dr. Czap has received research support from AAN.